The registered patent for Al-Ahliyya Amman Faculty of Pharmacy is published in a prestigious scientific journal

The Faculty of Pharmacy at Al-Ahliyya Amman University, led by Prof. Dr. Muhammad Al-Tanani, Dean of the Faculty, published the first clinical study on Corona patients in Jordan in the journal “Pharmaceuticals”, where a patent was registered for the drug used in Jordan, Europe and United States, where the faculty will apply for approval from the Jordan Food and Drug Administration for approval. In this regard, the President of the University, Prof. Dr. Sari Hamdan, expressed his pride in this achievement, which came with the continuous support of the Chairman of the Board of Directors, Dr. Maher Al-Hourani, and a culmination of the efforts of the Dean of the Faculty, Prof. Muhammad Al-Tanani, and the staff of the faculty, and with the support of the various academic and administrative departments at the university.